Market Trends Bristol Myers colorectal cancer drug cuts relapse risk (BMY)By admin8996erT0allJanuary 25, 2025 hapabapa/iStock Editorial via Getty ImagesBristol Myers Squibb (NYSE:BMY) announced Saturday that its checkpoint inhibitors Opdivo and Yervoy, when combined, reduced…
Market Trends Bristol sees annual $1.5B in cost savings by end of 2025By admin8996erT0allJanuary 13, 2025 arlutz73Bristol Myers Squibb (NYSE:BMY) said that ongoing initiatives to cut costs will lead to the realization of $1.5B in annual…